Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretic combined with ARB versus diuretic combined with CCB for primary hypertension
ChiCTR-IPR-17013419Phase 4Not yet recruiting
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in essential hypertension comparing Irbesartan + hydrochlorothiazide with Lercanidipine + hydrochlorothiazide (2 arms). Primary endpoints: 24-hour ambulatory blood pressure and Office blood pressure. Planned start Dec 2017; status: not yet recruiting.
02
Drugs
irbesartanlercanidipinehydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR-IPR-17013419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013419.